Antibe Therapeutics Inc. | Balance Sheet
Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,754.90
422.10
956.10
2,072.00
3,750.80
Total Accounts Receivable
473.10
263.70
1,495.70
1,201.40
1,283.90
Inventories
-
-
2,373.70
2,753.00
3,106.30
Other Current Assets
123.50
42.90
185.10
197.00
169.60
Total Current Assets
4,351.50
728.60
5,010.50
6,223.40
8,310.60
Net Property, Plant & Equipment
-
-
80.50
75.30
94.40
Intangible Assets
-
-
4,498.60
4,408.50
4,062.90
Other Assets
-
60.70
25.10
18.50
23.00
Total Assets
4,351.50
789.30
9,614.70
10,725.70
12,490.90
ST Debt & Current Portion LT Debt
-
-
1,643.20
1,152.30
1,537.40
Accounts Payable
-
-
772.80
1,109.50
1,472.10
Other Current Liabilities
1,032.90
452.10
589.30
885.30
422.80
Total Current Liabilities
1,032.90
452.10
3,005.20
3,147.10
3,432.30
Long-Term Debt
-
-
2,027.30
2,631.80
-
Deferred Taxes
-
-
608.10
309.90
-
Other Liabilities
-
-
-
1,083.50
1,083.50
Total Liabilities
1,032.90
452.10
5,640.60
7,172.30
4,515.80
Common Equity (Total)
3,318.60
337.20
3,974.10
3,553.40
7,975.10
Total Shareholders' Equity
3,318.60
337.20
3,974.10
3,553.40
7,975.10
Total Equity
3,318.60
337.20
3,974.10
3,553.40
7,975.10
Liabilities & Shareholders' Equity
4,351.50
789.30
9,614.70
10,725.70
12,490.90
About Antibe Therapeutics
View Profile
